Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing
Author
Date
2007-08-01Type

View/ Open
Access rights
Metadata
Show full item recordAbstract
Kaposi's sarcoma-associated herpesvirus (KSHV/human herpesvirus 8 [HHV8]) and Epstein-Barr virus (EBV/HHV4) are distantly related gammaherpesviruses causing tumors in humans. KSHV latency-associated nuclear antigen 1 (LANA1) is functionally similar to the EBV nuclear antigen-1 (EBNA1) protein expressed during viral latency, although they have no amino acid similarities. EBNA1 escapes cytotoxic lymphocyte (CTL) antigen processing by inhibiting its own proteosomal degradation and retarding its own synthesis to reduce defective ribosomal product processing. We show here that the LANA1 QED-rich central repeat (CR) region, particularly the CR2CR3 subdomain, also retards LANA1 synthesis and markedly enhances LANA1 stability in vitro and in vivo. LANA1 isoforms have half-lives greater than 24 h, and fusion of the LANA1 CR2CR3 domain to a destabilized heterologous protein markedly decreases protein turnover. Unlike EBNA1, the LANA1 CR2CR3 subdomain retards translation regardless of whether it is fused to the 5′ or 3′ end of a heterologous gene construct. Manipulation of sequence order, orientation, and composition of the CR2 and CR3 subdomains suggests that specific peptide sequences rather than RNA structures are responsible for synthesis retardation. Although mechanistic differences exist between LANA1 and EBNA1, the primary structures of both proteins have evolved to minimize provoking CTL immune responses. Simple strategies to eliminate these viral inhibitory regions may markedly improve vaccine effectiveness by maximizing CTL responses. Copyright © 2007, American Society for Microbiology. All Rights Reserved.
How to cite this document
Keywords
Language
Collections

Related items
Showing items related by title, author, creator and subject.
-
Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system
Soares, C. P.; Zuanon, J. A S
; Teresa, D. B.
; Fregonezi, P. A.
;
; Oliveira, M. R B
; Donadi, E. A.; Martinelli-Kläy, C. P.; Soares, E. G. (Histology and Histopathology, 2006) [Artigo]
The knowledge of cell-cycle control has shown that the capacity of malignant growth is acquired by the stepwise accumulation of defects in specific genes regulating cell growth. Histologic diagnosis might be improved by a ... -
Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma
Oliveira, Deilson Elgui de; Bacchi, Maura M.; Macarenco, Ricardo S.S.
; Tagliarini, José Vicente
; Cordeiro, Ricardo C.; Bacchi, Carlos E. (American Journal of Clinical Pathology, 2006) [Artigo]
Laryngeal carcinomas are aggressive neoplasms with controversial association with the human papillomavirus (HPV) and Epstein-Barr virus (EBV). So far, the impairment of p53 protein function and its impact on cellular ... -
Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus
Soares, Christiane Pienna; Neto, Carlos Benatti; Fregonezi, Paula Andrea Gabrielli; Teresa, Debora Barreto; Santos, Raimunda Telma de Macedo; Longatto-Filho, Adhemar; Maeda, Marina (Analytical and Quantitative Cytology and Histology, 2003) [Artigo]OBJECTIVE: To carry out a retrospective study to determine whether human papillomavirus (HPV) infection and immunohistochemical expression of p53 and proliferating cell nuclear antigen (PCNA) are related to the risk of ...